Rotkreuz, Switzerland

Andreas Wolfelschneider

This inventor holds 2 USPTO granted patents. Top assignee: Roche Molecular Systems, Inc.. Active years: 2018-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Wolfelschneider. Retrieved from https://idiyas.com/inventor/andreas-wolfelschneider

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Andreas Wolfelschneider

Introduction

Andreas Wolfelschneider is a notable inventor based in Rotkreuz, Switzerland. He has made significant contributions to the field of molecular diagnostics, particularly in the detection of Hepatitis A Virus (HAV). With a total of 2 patents, his work has advanced the methodologies used in biological sample analysis.

Latest Patents

Wolfelschneider's latest patents focus on innovative methods for detecting HAV in biological samples. These methods involve amplifying a target nucleic acid that contains the HAV sequence within a reaction mixture. The reaction mixture includes a biological sample that may harbor the target nucleic acid, along with a set of oligonucleotides. Additionally, his inventions provide kits designed for the effective detection of HAV.

Career Highlights

Andreas Wolfelschneider is currently associated with Roche Molecular Systems, Inc., a leading company in the field of molecular diagnostics. His expertise and innovative approaches have contributed to the company's advancements in diagnostic technologies.

Collaborations

Wolfelschneider has collaborated with esteemed colleagues such as Hermann Leying and Ning Lu. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in molecular diagnostics.

Conclusion

Andreas Wolfelschneider's contributions to the detection of HAV through innovative methodologies and collaborations highlight his significant role in advancing molecular diagnostics. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…